Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-011331

Chief Financial Officer acquired 50,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Buck Paul Chief Financial Officer 2013-02-22 Other acquisition +50,000 $0.25 $12,500 125,417 D: show line 1 in the form
Loading xslF345X03/v336217_4.xml…